Skip Navigation

Rheumatology 2005 44(Supplement 3):iii9; doi:10.1093/rheumatology/keh745
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Haskard, D. O.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Haskard, D. O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?




Supplement Article

OP20. IMAGING ENDOTHELIAL ACTIVATION IN INFLAMMATION

D. O. Haskard

Eric Bywaters Centre for Vascular Inflammation, Hammersmith Hospital, Imperial College, London, UK

Despite the important role that endothelial activation plays during inflammatory responses, molecular changes in endothelium are relatively inaccessible to clinical investigation. E-selectin (CD62E, ELAM-1) is an adhesion molecule expressed on the luminal surface of vascular endothelial cells in inflammation. It serves the function of initiating interactions between the endothelial cell and circulating leucocytes, preceding leukocyte diapedesis into inflamed tissue. E-selectin is not constitutively expressed by endothelial cells but is induced in response to cytokines during many inflammatory conditions, including sepsis, inflammatory bowel disease, atherosclerosis, and rheumatoid arthritis. E-selectin represents a potentially useful target for the molecular imaging of endothelial activation, since it is readily accessible to targeting agents. Furthermore, following expression, E-selectin is internalised, and agents conjugated to anti-E-selectin antibodies are taken with E-selectin into the cell, allowing accumulation of targeting agent and increased imaging signal. Monoclonal antibody 1.2B6 is a mouse antibody generated in our laboratory, which primarily reacts with E-selectin but also reacts with P-selectin at about four-fold lower affinity. Using this mAb, we have successfully imaged activated endothelium in vivo using radioscintography. The technique was first evaluated in porcine models of phytohaemaggltinin-induced and MSU crystal-induced arthritis, in which we found that the images of synovitis obtained with 111In-labelled mAb 1.2B6 F(ab')2 were significantly more focal and intense than those obtained with an isotype matched control mAb or 99mTc-labelled leukocytes. We have since shown that 111In-labelled mAb 1.2B6 F(ab')2 could image inflamed joints in patients with RA [1–3] and inflamed bowel in Crohn's Disease and Ulcerative Colitis [4]. More recently we have investigated the possibility of imaging E-selectin by magnetic resonance using anti-E-selectin conjugated ultrasmall superparamagnetic iron oxide nanoparticles.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.